EA201590124A1 - Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний - Google Patents

Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний

Info

Publication number
EA201590124A1
EA201590124A1 EA201590124A EA201590124A EA201590124A1 EA 201590124 A1 EA201590124 A1 EA 201590124A1 EA 201590124 A EA201590124 A EA 201590124A EA 201590124 A EA201590124 A EA 201590124A EA 201590124 A1 EA201590124 A1 EA 201590124A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
pneumatic
prevention
compositions
treatment
Prior art date
Application number
EA201590124A
Other languages
English (en)
Russian (ru)
Inventor
Роберт О. Кук
Юджин Р. Рейнолдз
Борис Шекунов
Сиеад И. Зегар
Original Assignee
Майкродоуз Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Майкродоуз Терапьютикс, Инк. filed Critical Майкродоуз Терапьютикс, Инк.
Publication of EA201590124A1 publication Critical patent/EA201590124A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA201590124A 2012-06-29 2013-06-28 Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний EA201590124A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261666258P 2012-06-29 2012-06-29
PCT/US2013/048723 WO2014005098A2 (en) 2012-06-29 2013-06-28 Compositions and methods for treating or preventing pneumovirus infection and associated diseases

Publications (1)

Publication Number Publication Date
EA201590124A1 true EA201590124A1 (ru) 2015-06-30

Family

ID=49778754

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201590124A EA201590124A1 (ru) 2012-06-29 2013-06-28 Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний

Country Status (17)

Country Link
US (2) US9040569B2 (enExample)
EP (1) EP2867216A4 (enExample)
JP (1) JP2015524391A (enExample)
KR (1) KR20150037946A (enExample)
CN (1) CN104507918A (enExample)
AU (1) AU2013282286A1 (enExample)
BR (1) BR112014032290A2 (enExample)
CA (1) CA2877941A1 (enExample)
EA (1) EA201590124A1 (enExample)
HK (2) HK1203956A1 (enExample)
IL (1) IL236476A0 (enExample)
IN (1) IN2014DN10680A (enExample)
MX (1) MX2014015340A (enExample)
NZ (1) NZ628880A (enExample)
TW (1) TWI516283B (enExample)
WO (1) WO2014005098A2 (enExample)
ZA (1) ZA201409073B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2867216A4 (en) 2012-06-29 2015-12-09 Microdose Therapeutx Inc COMPOSITIONS AND METHODS OF TREATING PNEUMOVIRAL INFECTIONS AND ASSOCIATED DISEASES
EP3233807B1 (de) * 2014-12-18 2019-09-04 MetrioPharm AG Kristalline form von 5-amino-2,3-dihydrophthalazin-1,4-dion natriumsalz, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
JP2018535277A (ja) * 2015-11-30 2018-11-29 ノヴァス・セラピューティクス・インコーポレーテッド 耳科学的予防および処置のための組成物および方法
WO2018071445A1 (en) 2016-10-11 2018-04-19 Microdose Therapeutx, Inc. Inhaler and methods of use thereof
MX2021001820A (es) * 2018-09-14 2021-04-28 Pharmosa Biopharm Inc Composicion farmaceutica para la liberacion controlada de farmacos acidos debiles y usos de los mismos.
CN109827875A (zh) * 2019-04-10 2019-05-31 上海市食品药品检验所 一种用于测定吸入制剂溶出度的装置和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495580B1 (en) * 1998-01-29 2002-12-17 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
WO1999038508A1 (en) 1998-01-29 1999-08-05 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
WO2002059132A1 (en) 2001-01-26 2002-08-01 Viropharma Incorporated Intermediate compounds useful for making antiviral compounds
EP1545513A2 (en) 2002-08-09 2005-06-29 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
EP1539691A2 (en) 2002-08-09 2005-06-15 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
EP2867216A4 (en) 2012-06-29 2015-12-09 Microdose Therapeutx Inc COMPOSITIONS AND METHODS OF TREATING PNEUMOVIRAL INFECTIONS AND ASSOCIATED DISEASES

Also Published As

Publication number Publication date
TWI516283B (zh) 2016-01-11
TW201416093A (zh) 2014-05-01
KR20150037946A (ko) 2015-04-08
WO2014005098A2 (en) 2014-01-03
WO2014005098A3 (en) 2014-02-27
MX2014015340A (es) 2015-03-05
ZA201409073B (en) 2016-08-31
EP2867216A4 (en) 2015-12-09
US9040569B2 (en) 2015-05-26
IL236476A0 (en) 2015-02-26
IN2014DN10680A (enExample) 2015-08-28
NZ628880A (en) 2016-08-26
US20140005239A1 (en) 2014-01-02
JP2015524391A (ja) 2015-08-24
US9504672B2 (en) 2016-11-29
HK1210163A1 (en) 2016-04-15
CN104507918A (zh) 2015-04-08
CA2877941A1 (en) 2014-01-03
HK1203956A1 (en) 2015-11-06
AU2013282286A1 (en) 2015-01-22
US20150209328A1 (en) 2015-07-30
EP2867216A2 (en) 2015-05-06
BR112014032290A2 (pt) 2017-06-27

Similar Documents

Publication Publication Date Title
EA201491028A8 (ru) Способ получения замещенных 5-фтор-1н-пиразолопиридинов
EA201301320A1 (ru) 4-арил-n-фенил-1,3,5-триазин-2-амины, которые содержат сульфоксиминную группу
EA201391719A1 (ru) Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний
MY183534A (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
EA201300604A1 (ru) Соединения, предназначенные для лечения респираторно-синцитиальных вирусных инфекций
IL230458A0 (en) Compounds for the treatment and prevention of respiratory syncytial viral disease
AU2011286276A8 (en) Substituted Biphenylene Compounds and methods of use thereof for the treatment of viral diseases
EA201590667A1 (ru) Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний
WO2012173682A3 (en) Compounds and methods for the treatment of isocitrate dehydrognase related diseases
MX2014003169A (es) Ligandos del receptor ep1.
HK1211290A1 (en) Heterocycle-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases
MX2013012233A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas sustituidas.
EA201590124A1 (ru) Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний
EA201400623A1 (ru) Новые 2h-индазолы в качестве антагонистов рецептора ep
TW201129572A (en) Compounds for treating respiratory syncytial virus infections
IN2013DN02555A (enExample)
PH12014501943A1 (en) Novel compounds for the treatment of dyslipidemia and related diseases
EP2792666A4 (en) PHORBOL-TYPE DITERPENE COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF VIRAL INFECTIOUS DISEASES COMPRISING THE SAME
EA019080B9 (ru) α-КРИСТАЛЛИЧЕСКАЯ ФОРМА КАРБАБЕНЗПИРИДА
IN2014DN10683A (enExample)
ZA201400442B (en) Compounds for the treatment and prophylaxis of respiratory syncytial virus disease